CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Uncover the advantages of investing in gold versus savings accounts. Learn which option suits your financial goals better.
23,656 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Bitcoin, Ethereum, and XRP flashed potential buy signals after a wide market drop, according to on-chain analytics. A...
Broadcom delivered solid quarterly results, but AI guidance disappointed some investors, sending shares lower. Analys...
When a top executive sells a chunk of stock, it draws attention. This guide examines brian chesky just sold, what ins...
New market data indicate AI-driven productivity gains are concentrated among a small group of mega-cap firms, fueling...
Honda is recalling nearly 900,000 vehicles after rear-suspension corrosion could cause loss of control. The recall co...
Bitcoin steadies near $62,000 as a major bitcoin demand drop sparks debate about whether the market is close to a cyc...
SpaceX is courting attention ahead of a potential Nasdaq debut. Some ETFs offer pre-IPO exposure via SPVs, but the st...
The Small Business Administration has paused new loans for green card holders, a policy shift that could disrupt immi...
Medicare Part B premiums rose to $202.90 per month in 2026, a 9.7% jump that tightens budgets for retirees. Here’s wh...
Investors are debating whether removing the weakest members of the S&P 500 improves long-term results. Here's what th...
A surge of mega IPOs in 2026 is minting new fortunes. Melinda French Gates’ advice for these newcomers centers on gen...